Evergreen Treatment Services and the University of Washington are collaborating in the START Study - Starting Treatment with Agonist Replacement Therapies. The study is comparing the effects of buprenorphine/naloxone and methadone on the liver. You may be eligible to participate if you are 18 or older, are seeking opioid treatment at ETS, and meet other study requirements. If you are eligible, you will receive either buprenorphine or methadone treatment at no cost. Compensation will be provided for your time and effort. Treatment will last up to 32 weeks.  For more information, please call 206-223-3644 and ask about the START study  

Evergreen Treatment Services is responsible for providing case management services to all clients of the HIV Enhanced Engagement Team, or HEET. HEET offers outreach, engagement, case management and housing assistance to homeless persons living with HIV/AIDS in Seattle.  For more information, please see the HEET Project Description. 

Ron Jackson, ETS Executive Director, was presented with the Nyswander/Dole award by Dr. Beny Primm at the 2003 conference of the American Association for the Treatment of Opioid Dependence in Washington, D.C. The prestigious award is named for Drs. Nyswander and Dole, who developed the concept of methadone maintenance as a treatment for opioid dependence. It is given to individuals who have been recognized by their peers for making an outstanding contribution to the field of opioid treatment. 

Ron Jackson, ETS Executive Director, served as a member of the Center for Substance Abuse Treatment consensus panel for the development of a new prescriptive manual on the delivery of medication-assisted treatment to individuals suffering from opioid addiction.  A copy of the in the manual, Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs, Treatment Improvement Protocol (TIP) 43, in Adobe Acrobat© format, can be downloaded by clicking on the title.